These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 3760120

  • 1. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
    Wajchenberg BL, Achando SS, Okada H, Czeresnia CE, Peixoto S, Lima SS, Goldman J.
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
    [Abstract] [Full Text] [Related]

  • 2. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS, Thompson DL.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [Abstract] [Full Text] [Related]

  • 3. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ, Saxena T, Lobo RA.
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [Abstract] [Full Text] [Related]

  • 4. Diagnostic evaluation of hirsutism in women.
    Farber M, Millan VG, Turksoy RN, Mitchell GW.
    Clin Obstet Gynecol; 1977 Mar; 20(1):1-9. PubMed ID: 837574
    [Abstract] [Full Text] [Related]

  • 5. The source(s) of estrogen production in hirsute women with polycystic ovarian disease as determined by simultaneous adrenal and ovarian venous catheterization.
    Wajchenberg BL, Achando SS, Mathor MM, Czeresnia CE, Giannella Neto D, Kirschner MA.
    Fertil Steril; 1988 Jan; 49(1):56-61. PubMed ID: 3121397
    [Abstract] [Full Text] [Related]

  • 6. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R, Black VY, Knochenhauer ES, Hines GA, Boots LR.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [Abstract] [Full Text] [Related]

  • 7. The adrenal cortex and virilization.
    McKenna TJ, Cunningham SK, Loughlin T.
    Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
    [Abstract] [Full Text] [Related]

  • 8. Suppression of testosterone and androstenedione porduction rates with dexamethasone in women with idiopathic hirsutsm and polycystic ovaries.
    Bardin CW, Hembree WC, Lipsett MB.
    J Clin Endocrinol Metab; 1968 Sep; 28(9):1300-6. PubMed ID: 4300558
    [No Abstract] [Full Text] [Related]

  • 9. Idiopathic hirsutism--an ovarian abnormality.
    Kirschner MA, Zucker IR, Jespersen D.
    N Engl J Med; 1976 Mar 18; 294(12):637-40. PubMed ID: 1246257
    [Abstract] [Full Text] [Related]

  • 10. Combined ovarian and adrenal vein catheterization to determine the site(s) of androgen overproduction in hirsute women.
    Kirschner MA, Jacobs JB.
    J Clin Endocrinol Metab; 1971 Aug 18; 33(2):199-209. PubMed ID: 4935635
    [No Abstract] [Full Text] [Related]

  • 11. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar 18; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 12. The origin of androgen synthesis in polycystic ovary syndrome.
    Milewicz A, Silber D, Mielecki T.
    Obstet Gynecol; 1983 Nov 18; 62(5):601-4. PubMed ID: 6225965
    [Abstract] [Full Text] [Related]

  • 13. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
    Pang S, Wang M, Jeffries S, Riddick L, Clark A, Estrada E.
    J Clin Endocrinol Metab; 1992 Jul 18; 75(1):243-8. PubMed ID: 1535633
    [Abstract] [Full Text] [Related]

  • 14. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
    Bidzińska B, Tworowska U, Demissie M, Milewicz A.
    Przegl Lek; 2000 Jul 18; 57(7-8):393-6. PubMed ID: 11109312
    [Abstract] [Full Text] [Related]

  • 15. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA, Mukherjee JJ, Kola B, Isidori AM, Hanson JA, Dacie JE, Reznek R, Monson JP, Grossman AB.
    Clin Endocrinol (Oxf); 2003 Jul 18; 59(1):34-43. PubMed ID: 12807501
    [Abstract] [Full Text] [Related]

  • 16. Hirsutism and virilism in women.
    Kirschner MA.
    Spec Top Endocrinol Metab; 1984 Jul 18; 6():55-93. PubMed ID: 6084314
    [Abstract] [Full Text] [Related]

  • 17. Effect of dexamethasone on serum cortisol and androgen levels in hirsute patients.
    Abraham GE, Maroulis GB, Buster JE, Chang RJ, Marshall JR.
    Obstet Gynecol; 1976 Apr 18; 47(4):395-402. PubMed ID: 130572
    [Abstract] [Full Text] [Related]

  • 18. Androgen and estrogen formation in women with ovarian hyperthecosis.
    Aiman J, Edman CD, Worley RJ, Vellios F, MacDonald PC.
    Obstet Gynecol; 1978 Jan 18; 51(1):1-9. PubMed ID: 619322
    [Abstract] [Full Text] [Related]

  • 19. Adrenal abnormalities in polycystic ovary syndrome.
    Loughlin T, Cunningham S, Moore A, Culliton M, Smyth PP, McKenna TJ.
    J Clin Endocrinol Metab; 1986 Jan 18; 62(1):142-7. PubMed ID: 3079598
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome. Dexamethasone and GnRH-agonist administration.
    Fulghesu AM, Lanzone A, Fortini A, Guido M, Caruso A, Mancuso S.
    J Reprod Med; 1993 May 18; 38(5):387-92. PubMed ID: 8320677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.